Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis
Kidney International · 2024-07 · 106 (1) · 67-84
DOI: 10.1016/j.kint.2024.02.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2024-07. Verfasst von Josep M Cruzado und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Transplantation, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain; De…. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, Podocytes, Macrophage Colony-Stimulating Factor, Hyaluronan Receptors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Generalitat de Catalunya, European Regional Development Fund, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Parietal epithelial cells (PECs) are kidney progenitor cells with similarities to a bone marrow stem cell niche. In focal segmental glomerulosclerosis (FSGS) PECs become activated and contribute to extracellular matrix deposition. Colony stimulating factor-1 (CSF-1), a hematopoietic growth factor, acts via its specific receptor, CSF-1R, and has been implicated in several glomerular diseases, although its role on PEC activation is unknown. Here, we found that CSF-1R was upregulated in PECs and podocytes in biopsies from patients with FSGS. Through in vitro studies, PECs were found to constitutively express CSF-1R. Incubation with CSF-1 induced CSF-1R upregulation and significant transcriptional regulation of genes involved in pathways associated with PEC activation. Specifically, CSF-1/CSF-1R activated the ERK1/2 signaling pathway and upregulated CD44 in PECs, while both ERK and CSF-1R inhibitors reduced CD44 expression. Functional studies showed that CSF-1 induced PEC proliferation and migration, while reducing the differentiation of PECs into podocytes. These results were validated in the Adriamycin-induced FSGS experimental mouse model. Importantly, treatment with either the CSF-1R-specific inhibitor GW2580 or Ki20227 provided a robust therapeutic effect. Thus, we provide evidence of the role of the CSF-1/CSF-1R pathway in PEC activation in FSGS, paving the way for future clinical studies investigating the therapeutic effect of CSF-1R inhibitors on patients with FSGS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Transplantation, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain; Department of Nephrology, Hospital Universitari Bellvitge, Barcelona, Sp…
- Department of Nephrology, Hospital Universitari Bellvitge, Barcelona, Spain; Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.
- Cellular Biology in Renal Diseases Laboratory, IIS Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
- Department of Nephrology and Transplantation, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
- Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt am Main, Germany.
- Department of Nephrology, Hospital Universitari Bellvitge, Barcelona, Spain.
Förderung
- Generalitat de Catalunya
- European Regional Development Fund
- Instituto de Salud Carlos III
Zitieren
APA
Cruzado, J. M., Manonelles, A., Rayego-Mateos, S., Doladé, N., Amaya-Garrido, A., Varela, C., Guiteras, R., Mosquera, J. L., Jung, M., Codina, S., Martínez-Valenzuela, L., Draibe, J., Couceiro, C., Vigués, F., Madrid, Á., Florian, M. C., Ruíz-Ortega, M., & Sola, A. (2024). Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis. Kidney International, 106(1), 67-84. https://doi.org/10.1016/j.kint.2024.02.010
Vancouver
Cruzado JM, Manonelles A, Rayego-Mateos S, Doladé N, Amaya-Garrido A, Varela C, et al. Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis. Kidney International. 2024;106(1):67-84. doi:10.1016/j.kint.2024.02.010
BibTeX
@article{Cruzado2024,
author = {Cruzado, Josep M and Manonelles, Anna and Rayego-Mateos, Sandra and Doladé, Núria and Amaya-Garrido, Ana and Varela, Cristian and Guiteras, Roser and Mosquera, Jose Luis and Jung, Michaela and Codina, Sergi and Martínez-Valenzuela, Laura and Draibe, Juliana and Couceiro, Carlos and Vigués, Francesc and Madrid, Álvaro and Florian, M Carolina and Ruíz-Ortega, Marta and Sola, Anna},
title = {Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis},
journal = {Kidney International},
year = {2024},
volume = {106},
number = {1},
pages = {67--84},
doi = {10.1016/j.kint.2024.02.010}
}
EUVIMED